(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 11.98% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.23%.
Sight Sciences's revenue in 2026 is $77,363,000.On average, 10 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,671,301,592, with the lowest SGHT revenue forecast at $4,408,724,498, and the highest SGHT revenue forecast at $4,861,996,722. On average, 10 Wall Street analysts forecast SGHT's revenue for 2027 to be $5,167,238,543, with the lowest SGHT revenue forecast at $4,472,235,535, and the highest SGHT revenue forecast at $5,665,767,781.
In 2028, SGHT is forecast to generate $5,901,233,872 in revenue, with the lowest revenue forecast at $5,358,041,685 and the highest revenue forecast at $6,198,806,844.